David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$354M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$309M |
| 3 |
Microsoft
MSFT
|
+$307M |
| 4 |
Automatic Data Processing
ADP
|
+$266M |
| 5 |
Citigroup
C
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$567M |
| 2 |
Fidelity National Information Services
FIS
|
+$410M |
| 3 |
Medtronic
MDT
|
+$359M |
| 4 |
Amazon
AMZN
|
+$297M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.15% |
| 2 | Consumer Discretionary | 12.74% |
| 3 | Healthcare | 11.89% |
| 4 | Financials | 8.05% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
CytomX Therapeutics
CTMX
$723M
| $2.49M | ﹤0.01% |
337,004
+4,810
| +1% | +$47.4K |
|
2152
PUT
Ovintiv
OVV
$17.8B
| $2.48M | ﹤0.01% |
108,000
+16,000
| +17% | +$366K |
|
2153
CALL
Synchrony
SYF
$26B
| $2.48M | ﹤0.01% |
72,800
+51,600
| +243% | +$1.77M |
|
|
CAI
2154
DELISTED
CAI International, Inc.
CAI
| $2.47M | ﹤0.01% |
113,382
-48,000
| -30% | -$1.06M |
|
2155
Amphenol
APH
$199B
| $2.47M | ﹤0.01% |
102,232
-372,208
| -78% | -$8.58M |
|
2156
Center Bancorp
CNOB
$1.61B
| $2.46M | ﹤0.01% |
111,012
-3,095
| -3% | -$67.2K |
|
2157
PUT
ATI
ATI
$29B
| $2.46M | ﹤0.01% |
+121,600
| New | +$2.57M |
|
2158
CALL
Viatris
VTRS
$19.4B
| $2.46M | ﹤0.01% |
124,200
+62,100
| +100% | +$1.22M |
|
|
SEMG
2159
PUT
DELISTED
SEMGROUP CORPORATION
SEMG
| $2.45M | ﹤0.01% |
150,000
+50,000
| +50% | +$584K |
|
2160
PUT
Aptiv
APTV
$9.61B
| $2.45M | ﹤0.01% |
28,000
| – | – |
|
2161
PUT
BorgWarner
BWA
$13.2B
| $2.44M | ﹤0.01% |
+75,658
| New | +$2.44M |
|
2162
CALL
Cummins
CMI
$79.6B
| $2.44M | ﹤0.01% |
15,000
-3,700
| -20% | -$592K |
|
2163
Red Robin
RRGB
$191M
| $2.44M | ﹤0.01% |
73,206
+51,460
| +237% | +$1.69M |
|
2164
UNIFI
UFI
$140M
| $2.43M | ﹤0.01% |
110,863
-22,337
| -17% | -$440K |
|
2165
Axsome Therapeutics
AXSM
$10.9B
| $2.43M | ﹤0.01% |
119,951
+85,195
| +245% | +$2.19M |
|
2166
Ralph Lauren
RL
$21.6B
| $2.43M | ﹤0.01% |
25,418
-40,817
| -62% | -$4.04M |
|
2167
Revvity
RVTY
$14.1B
| $2.43M | ﹤0.01% |
28,483
-51,843
| -65% | -$4.54M |
|
2168
Innospec
IOSP
$2.36B
| $2.42M | ﹤0.01% |
27,150
+6,556
| +32% | +$588K |
|
2169
PUT
Motorola Solutions
MSI
$80.6B
| $2.42M | ﹤0.01% |
14,200
+9,800
| +223% | +$1.68M |
|
2170
Ingles Markets
IMKTA
$1.59B
| $2.42M | ﹤0.01% |
62,192
+32,626
| +110% | +$1.16M |
|
2171
CALL
Tandem Diabetes Care
TNDM
$1.49B
| $2.41M | ﹤0.01% |
40,900
-14,800
| -27% | -$945K |
|
|
NXGN
2172
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.41M | ﹤0.01% |
153,862
-9,288
| -6% | -$154K |
|
|
BFX
2173
DELISTED
BowFlex Inc.
BFX
| $2.4M | ﹤0.01% |
1,779,017
+639,117
| +56% | +$1M |
|
|
HOLI
2174
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $2.39M | ﹤0.01% |
157,585
+95,155
| +152% | +$1.58M |
|
2175
UDR
UDR
$12.2B
| $2.39M | ﹤0.01% |
+49,349
| New | +$2.32M |
|
Similar funds
David Shaw's Q3 2019 Portfolio in Review
As of Q3 2019, David Shaw held 4,189 positions worth $81.2B, up 1.3% from $80.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw withdrew a net $3.14B in Q3 2019, closing 422 positions and reducing 1,391 holdings. Its most notable exit was Anadarko Petroleum, an estimated $567M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $310M.
- David Shaw's largest Q3 2019 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 3,554,658 shares worth $310M.
- David Shaw added most to PayPal in Q3 2019, an estimated $354M increase.
- David Shaw's biggest Q3 2019 reduction was Fidelity National Information Services, cutting an estimated $410M.
- David Shaw fully exited Anadarko Petroleum in Q3 2019, selling an estimated $567M.
- David Shaw's ten largest holdings make up 10% of its $81.2B portfolio in Q3 2019.
- David Shaw opened 550 new positions and closed 422 in Q3 2019.
- David Shaw's portfolio value rose 1.3% quarter-over-quarter to $81.2B.
Based on D.E. Shaw & Co's 13F filing for Q3 2019, filed 14 Nov 2019.